Print Page | Contact Us | Sign In | Join ASFA
October 2020 Webinar - CAR-T Cell Therapy for Multiple Myeloma: What Have We Learned?
Register Tell a Friend About This EventTell a Friend

 Export to Your Calendar 10/7/2020
When: October 7, 2020
12:00 PM
Where: GoToWebinar
United States
Contact: ASFA Head Office

Online registration is available until: 10/7/2020
« Go to Upcoming Event List  

Title: CAR-T Cell Therapy for Multiple Myeloma: What Have We Learned?
Date: Wednesday, October 7, 2020
Time: 12:00pm - 1:00pm ET
Speaker: Adam D. Cohen, MD

Dr. Cohen received his medical degree and Internal medicine training from the University of Pennsylvania and completed his Hematology/Medical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York. Board certified in internal medicine, medical oncology, and hematology, Dr. Cohen is a member of ASH, ASCO, AACR and the International Myeloma Society, and a reviewer for a number of peer-reviewed journals. He has written dozens of original articles, book chapters, and reviews on cancer immunotherapy, multiple myeloma, amyloidosis, and stem cell transplant.

Dr. Cohen is currently Director of Myeloma Immunotherapy and an Assistant Professor in the Hematology/Oncology Division at the Abramson Cancer Center of the University of Pennsylvania in Philadelphia.

Learning Objectives:

  1. Describe rationale for CAR T cell therapy for myeloma and current targets;
  2. Identify CAR T cell products currently in development for myeloma;
  3. Understand clinical activity and toxicities of CAR T cell therapy for myeloma

©2020 American Society for Apheresis (ASFA). All rights reserved.
American Society for Apheresis and the ASFA logo are registered service marks.